According to Reuters, sources said the Trump administration is stepping up measures to prevent China from acquiring US advanced technology for commercial purposes and then diverting it to military use.

Senior U.S. officials agreed at a meeting on Wednesday that three measures could be used to stop Chinese companies from buying certain optical materials, radar equipment and semiconductors from the United States. However, these measures have not yet been finalized.

Hawks inside the US government say it's time to update US regulations in accordance with China's policies, because US shipments of goods abroad are largely based on whether they are approved for civilian or military use.

The source said that one of the provisions involving a civil or "citizen" exemption will change, which allows certain U.S. technology to be exported without a license, and the United States will now cancel the "exempt" clause against China because the The terms simplify the export of products such as FPGA integrated circuits.

A Xilinx spokesperson said in a statement: "Xilinx is aware of the proposed increase in export restrictions to China and is closely monitoring the situation. If it is issued, we will comply with any new regulations of the United States Department of Commerce."

Intel declined to comment.

The source said that the final change in "civil immunity" would also force foreign companies to ship certain US goods to China not only with the approval of their own government, but also with the approval of the US government.

However, some insiders pointed out that this decision may push Chinese customers into the arms of American company competitors!

Jiwei has previously reported that the US government will increase restrictions on Huawei in order to divert its main contradiction of ineffective domestic epidemic prevention.

Judging from the current situation, with the further outbreak of the US domestic epidemic, such measures and news may increase further in the near future, but whether it can be finally implemented remains to be discussed.